Biontech and Pfizer to produce COVID-19 vaccine by the end of the year

Both Biontech and Pfizer say 100 million of these vaccines will be available by the end of 2020.

The US government has announced $ 2 billion for the purchase of 100 million covid-19 vaccines, which are currently being jointly developed by Biontech and Pfizer.

A statement from the two companies said the United States would receive 100 million doses of the vaccine in the first phase, and the country would purchase another 500 million more in the future.

BionTech in Germany and Pfizer in the United States have launched a study to develop a vaccine against covid-19 in recent months, pledging to make the drug available to the rest of the world. .

The two companies say 100 million of these vaccines will be produced by the end of 2020, while at least 1.3 billion more vaccines will be produced by the end of 2021.

Earlier this month, Pfizer and Biontech announced the preliminary results of a trial of 45 vaccines, confirming the quality of the vaccine, and plans for a second phase. in Brazil and Argentina soon.